McKesson stock trades near USD 892 as guidance rises
Published on 09/21/2026 at 21:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
McKesson stock (ISIN US58155Q1031) traded at USD 892.57 on September 21, 2026, giving the company a market value of USD 101.98 billion and a P/E ratio of 22.21. The shares were up 2.05 percent from the previous close of USD 874.65, with volume at 280.59K.
Guidance stays in view
According to TradingView on September 21, 2026, McKesson raised fiscal EPS guidance to USD 44.20 to USD 45.00, after a prior range that was USD 0.40 lower. The same report said Wellverse Medical-Surgical sales rose about 4 percent while adjusted operating profit fell about 20 percent because of mix and one-time costs.
Valuation remains rich
MarketBeat said on September 21, 2026 that McKesson carried a consensus price target of USD 973.44, based on 18 analysts, with a Moderate Buy rating and implied upside of 11.4 percent from USD 874.02. Robinhood put the day's high at USD 881.04 and the low at USD 864.17, while volume reached 2.69 million shares.
Stock holds the range
The stock closed at USD 874.65 on September 18, 2026, with a 52-week range of USD 687.68 to USD 999.00. At that level, McKesson stock stayed below its yearly high and above the low, with market capitalization above USD 101.9 billion.
McKesson stock facts
- Company: McKesson Corporation
- ISIN: US58155Q1031
- Ticker: MCK
- Trading venue: NYSE
- Price (as of September 21, 2026): USD 892.57
- Market capitalization: USD 101.98 billion (as of September 21, 2026)
- Sector / Industry: Healthcare / Medical Distribution
- Index membership: S&P 500
